ArticlePDF Available

Mastic Gum Kills Helicobacter pylori

Authors:

Abstract

To the Editor: Even low doses of mastic gum — 1 mg per day for two weeks — can cure peptic ulcers very rapidly, but the mechanism responsible has not been clear. We have found that mastic is active against Helicobacter pylori, which could explain its therapeutic effect in patients with peptic ulcers. Mastic is a resinous exudate obtained from the stem and the main leaves of Pistacia lentiscus. It is used as a food ingredient in the Mediterranean region. Clinically, mastic has been effective in the treatment of benign gastric ulcers1 and duodenal ulcers.2 In rats, mastic showed cytoprotective . . .
New England Journal of Medicine
December 24, 1998
Vol. 339, No.26, pp. 1946
Mastic Gum Kills Helicobacter pylori
Farhad U. Huwez, M.R.C.P., Ph.D.
Barnet General Hospital, Barnet, Herts EN5 3DJ, United Kingdom
Debbie Thirlwell, B.Sc., Alan Cockayne, Ph.D.,
Dlawer A.A. Ala'Aldeen, Ph.D., M.R.C.Path.
University Hospital, Nottingham NG7 2UH, United Kingdom
To the Editor: Even low doses of mastic gum - 1 g per day for two weeks - can cure peptic
ulcers very rapidly, but the mechanism responsible has not been clear. We have found that mastic is
active against Helicobacter pylori, which could explain its therapeutic effect in patients with peptic
ulcers. Mastic is a resinous exudate obtained from the stem and the main leaves of Pistacia lentiscus. It
is used as a food ingredient in the Mediterranean region. Clinically, mastic has been effective in the
treatment of benign gastric ulcers1 and duodenal ulcers2. In rats, mastic showed cytoprotective and mild
antisecretory properties3. We assessed the antibacterial properties of mastic against H. pylori.
The H. pylori strains NCTC 11637 (a standard reference strain) and six fresh clinical isolates
(three were sensitive and three were resistant to metronidazole) were maintained by passage on 7
percent horse chocolate blood agar or in IsoSensitest broth (with 5 percent fetal-calf serum) at 37°C in
a microaerobic atmosphere (6 percent oxygen and 5 percent carbon dioxide in nitrogen).
Mastic was prepared as a stock solution in ethanol at a concentration of 50 mg per milliliter and
diluted in the broth culture (containing 107 cells of H. pylori per milliliter) for a final concentration
ranging from 0.0075 to 1.0 mg per milliliter. Ethanol was added to control cultures at appropriate
concentrations. The cultures were incubated, 10-µl aliquots were obtained and seeded on agar plates at
various times for up to 48 hours, and the minimal bactericidal concentrations (the minimal
concentration of drug required to kill 99.9 percent of the organisms in the medium after overnight
incubation) were determined.
Mastic killed the H. pylori NCTC 11637 strain and the six clinical isolates (reduction in the
viable count by a factor of 1000) irrespective of the organism's level of susceptibility to
nitroimidazoles. The minimal bactericidal concentration at 24 hours for all strains that were studied
was 0.06 mg of the crude mastic per milliliter. At lower concentrations, bacterial growth was still
significantly inhibited, with a clear postantibiotic effect even at the lowest concentration used, 0.0075
mg per milliliter. Mastic induced clear ultrastructural changes in the organism, as demonstrated by
transmission electron microscopy (data not shown).
These results suggest that mastic has definite antibacterial activity against H. pylori. This
activity may at least partly explain the anti-peptic-ulcer properties of mastic1,2. Examination of the anti-
H. pylori effect of the various constituents of mastic, which have been recently identified4, may
pinpoint the active ingredient. Mastic is cheap and widely available in Third World countries;
therefore, our data should have important implications for the management of peptic ulcers in
developing countries.
References:
1. Huwez FU, Al-Habbal MJ. Mastic in treatment of benign gastric ulcers. Gastroenterol Japon
1986;21:273-4.
2. Al-Habbal MJ, Al-Habbal Z, Huwez FU. A double-blind controlled clinical trial of mastic and
placebo in the treatment of duodenal ulcer. J Clin Exp Pharm Physiol 1984;11:541-4.
3. Al-Said MS, Ageel AM, Parmar NS, Tariq M. Evaluation of mastic, a crude drug obtained from
Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J Ethnopharmacol 1986;15:271-8.
4. Papageorgiou VP, Bakola-Christianopoulou MN, Apazidou KK, Psarros EE. Gas chromatographic-
mass spectroscopic analysis of the acidic triterpenic fraction of mastic gum. J Chromatogr
1997;769:263-73.
... CMG is known as a traditional medicine, where the prominent Greek physician Hippocrates (4th century BC) and later Dioscorides and Galen (1st and 2nd century AD) noted its therapeutic properties, such as for indigestion and blood and respiratory problems [1]. Mastic gum's use in "curing" peptic ulcers and providing protection against Helicobacter pylori rapidly entered mainstream academic literature after a 1998 New England Journal of Medicine publication [2]. Since then, research has continued to reveal the rich collection of antimicrobial, anti-inflammatory, and antioxidant properties within CMG, rendering it a versatile therapeutic agent for addressing various health conditions. ...
Article
Full-text available
Chios mastic gum (CMG) is a resin obtained from the Pistacia lentiscus var. Chia tree that grows in the Mediterranean. For millennia, it has been renowned for its medicinal properties, but recently, CMG has gained attention due to its pronounced anti-inflammatory and antioxidative properties and its use in oral health, inflammatory bowel disease, cancer, and risk factors related to cardiovascular and metabolic diseases. This narrative review seeks to briefly overview its bioactive constituents and examine and describe its potential as a cardiometabolic disease (CMD) phytotherapeutic. The results of clinical trials and in vivo, in vitro, and in silico studies provide accumulating evidence of the mechanisms underlying CMG’s impacts on lipid and glucose metabolism, cardiovascular and hepatic health, inflammation, oxidative stress, body composition, and microbiota. Despite the relatively limited studies with mixed results, they have provided the foundation to understand the strengths, weaknesses, and opportunities moving forward that may help to establish CMG and its bioactives as viable therapeutics for CMD.
Preprint
Full-text available
Background: Helicobacter pylori (H. pylori) infection remains a persistent health problem in Korea, where the prevalence of peptic ulcers and gastric cancer is high. This study aimed to determine whether phospholipid-based lipid nanoparticles containing curcumin and mastic gum are beneficial in the treatment of H. pylori infection. Materials and Methods: This was a prospective single-arm pilot study. Patients with confirmed H. pylori infection (delta >8.5) according to a ¹³C-urea breath test (UBT) were included in this study. The study's primary endpoint was to determine the change in the delta UBT values after consuming curcumin-mastic concentrate powder three times a day for 10 days. The rates of H. pylori eradication with standard H. pylori eradication regimens, clarithromycin-based triple therapy, and bismuth quadruple therapy were evaluated. Results: A total of 25 patients participated in the study, with a mean age of 64.44±10.03 years, including 16 male (64.0%) and nine female (36.0%). After 10 days of consuming curcumin-mastic concentrate, the mean delta value of the UBT significantly decreased from 31.85±21.54 to 21.36±21.47 (mean difference=-10.49, P=0.018). Six (24.0%) patients achieved H. pylori eradication after ingesting a curcumin-mastic concentrate (delta value <2.5). The H. pylori eradication rate increased to 56.5% after clarithromycin-based triple therapy and to 85.0% after additional bismuth quadruple therapy. No adverse events related to curcumin-mastic concentrate intake were reported during the study period. Conclusions: Curcumin-mastic concentrate has been demonstrated to reduce H. pylori activity safely in humans. This study suggests that administering curcumin-mastic concentrate before H. pylori eradication treatment may improve eradication rates; however, further large randomized controlled trials are needed to confirm this finding.
Article
Full-text available
The investigation of a skin adhesive based on amylopectin and mastic gum for attaching skin sensors are reported. The material provides reliable adhesion and is, at the same time, readily washable from the skin due to the hydrophilic character of the amylopectin compound. The effect of water and glycerol content on the adhesion properties in combination with polyimide‐based substrates is assessed and optimize the material for homogeneous and washable on‐skin applications. This results show that the adhesive material can withstand a shear stress of 88.7 ± 5.30 kPa in a lap shear test. The adhesive material can also be easily rendered conductive by adding sodium chloride. Impedance spectroscopy is performed on the conductive adhesive material to assess the impedance behavior during drying conditions over 24 h in comparison to commercial electrolyte gel. While the conductive adhesion material's initial impedance is slightly higher than the commercial gel, the long‐term assessment demonstrates a significantly improved stability over time. In conclusion, this study develops a skin adhesive combining amylopectin and mastic gum, demonstrating promising adhesion strength and conductivity properties, thus potentially addressing current stability challenges in skin‐sensor applications.
Article
Full-text available
The rising risks of food microbial contamination and foodborne pathogens resistance have prompted an increasing interest in natural antimicrobials as promising alternatives to synthetic antimicrobials. Essential oils (EOs) obtained from natural sources have shown promising anticancer, antimicrobial, and antioxidant activities. EOs extracted from the resins of Pistacia lentiscus var. Chia are widely utilized for the treatment of skin inflammations, gastrointestinal disorders, respiratory infections, wound healing, and cancers. The therapeutic benefits of P. lentiscusessential oils (PO) are limited by their low solubility, poor bioavailability, and high volatility. Nanoencapsulation of PO can improve their physicochemical properties and consequently their therapeutic efficacy while overcoming their undesirable side effects. Hence, PO was extracted from the resins of P. lentiscusvia hydrodistillation. Then, PO was encapsulated into (2-hydroxypropyl)-beta-cyclodextrin (HPβCD) via freeze-drying. The obtained inclusion complexes (PO-ICs) appeared as round vesicles (22.62 to 63.19 nm) forming several agglomerations (180 to 350 nm), as detected by UHR-TEM, with remarkable entrapment efficiency (89.59 ± 1.47%) and a PDI of 0.1475 ± 0.0005. Furthermore, the encapsulation and stability of PO-ICs were confirmed via FE-SEM, 1 H NMR, 2D HNMR (NOESY), FT-IR, UHR-TEM, and DSC. DSC revealed a higher thermal stability of the PO-ICs, reaching 351.0°C. PO-ICs exerted substantial antibacterial activity against Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli as compared to free PO. PO-ICs showed significant enhancement in the antibacterial activity of the encapsulated PO against S. aureus with an MIC90 of 2.84 mg/mL and against P. aeruginosa with MIC90 of 3.62 mg/ mL and MIC50 of 0.56 mg/mL. In addition, PO-ICs showed greater antimicrobial activity against E. coli by 6-fold with an MIC90 of 0.89 mg/mL, compared to free PO, which showed an MIC90 of 5.38 mg/mL. In conclusion, the encapsulation of PO into HPβCD enhanced its aqueous solubility, stability, and penetration ability, resulting in a significantly higher antibacterial activity.
Article
Full-text available
Between 2018 and 2021, several mastic trees (Pistacia lentiscus var. Chia) sampled in the field and the nursery of the Chios Mastiha Growers Association (CMGA) were analyzed to determine the cause of dominant diseases. Symptoms included defoliation, leaf, and twig blight, wilting and/or apoplexy of trees and apoplexy of young hardwood cuttings. Moreover, brown discoloration had also been observed on older woody parts of the trees such as branches and tree trunks. Several pathogens have been isolated and identified as the causing agents. Neopestalotiopsis and Alternaria species were isolated consistently from necrotic tissues of mastic trees (branches, twigs, and leaves) in the field and the nursery. All fungal isolates’ pathogenicity was confirmed by applying Koch’s postulates on young mastic trees under glasshouse conditions. Fungal pathogens were identified by sequence analyses of the ITS, β-tubulin, and histone gene regions. Alternaria species were analyzed further by sequencing the endopolygalacturonase (endoPG) and the Alternaria major allergen (Alta1) genes. More specifically, the isolates were identified as Neopestalotiopsis clavispora, Alternaria arborescens, and A. alternata based on morphological features and sequence analyses. This is the first report of N. clavispora, A. arborescens, and A. alternata on P. lentiscus var. Chia.
Article
Full-text available
Seedlings from the germinated seeds of Pistacia lentiscus were cultured in plant growth chambers for three months. Then, the plants were separated into three groups. Each group was cultured under different conditions. The first group was left to grow under normal Mediterranean conditions, as those recorded in spring. The other group was subjected to a ten-day heat stress while the last one also suffered a cold stress for ten days. The anatomical features of the leaves (leaf thickness, epidermal cell thickness, number of palisade layers, and development) between these three groups differed. The stressed plants accumulated large amounts of phenolics within their mesophyll cells. The biomass of the cold-stressed plants was minor, while it was high for the control plants. The oxidative stress was hardly detectable in the leaves of the control plants, while their heat-stressed counterparts suffered the highest concentration of reactive oxygen species. Differences concerning the absorption spectra of the three groups of leaves were not significant. An interesting incompatibility between the three groups concerned the expression of L-Dopa Decarboxylase, which climbed significantly in the heat-stressed plants. Finally, an interesting variation was observed concerning the concentrations of some biogenic amines/amino acids. This variation can be correlated to the other stress-induced reactions of the plants and, in some cases, was impressive. In conclusion, environmental stress can shift Pistacia lentiscus’ metabolism to synthesize different biogenic products, which can be considered as exploitable for the pharmaceutical or food industry.
Chapter
Medicinal traditional plants are a source of inspiration for the discovery of new bioactive substances. Plant infusions, extracts, and essential oils are known for their diverse biological activity since they are rich in secondary metabolites. The Mediterranean area in general and Lebanon in particular is known for its plant diversity due to its climate and geographical location. This chapter will provide an overview of Lebanese plants with antimicrobial activity. Many of these plants are known for their culinary and traditional medicinal uses for the treatment of different ailments. The main plant families discussed here include Amaryllidaceae, Anacardiaceae, Apiaceae, Asteraceae, Berberidaceae, Cannabaceae, Cistaceae, Lamiaceae, Myrtaceae, Pinaceae, Portulacaceae, Ranunculaceae, Rutaceae, Rosaceae, and others.
Article
1. A double‐blind clinical trial was carried out on thirty‐eight patients with symptomatic and endoscopically proven duodenal ulcer to compare the therapeutic responses to mastic (1 g daily, twenty patients) and placebo (lactose, 1 g daily, eighteen patients) given orally over a period of 2 weeks. 2. Symptomatic relief was obtained in sixteen (80%) patients on mastic and in nine (50%) patients on placebo, while endoscopically proven healing occurred in fourteen (70%) patients on mastic and four (22%) patients on placebo. The differences between treatments were highly significant ( P <0.01). Mastic was well tolerated and did not produce side effects. 3. It is concluded that mastic has an ulcer healing effect, but further studies are needed to establish its role in treating peptic ulcer.
Article
The acidic fraction of mastic gum, the resin of Pistacia lentiscus L. var. Chia, was analyzed using GC–MS. Ten triterpenoid acids – three already known – were tentatively identified as their methyl esters i.e., moronic, oleanonic, isomasticadienonic, masticadienonic, 18αH-oleanonic, oleanolic, 3-epiisomasticadienolic, masticadienolic, 3α-acetoxyisomasticadienolic and 3α-acetoxymasticadienolic acids.
Article
The effect of mastic, a concrete resinous exudate obtained from the stem of the tree Pistacia lentiscus, has been studied on experimentally-induced gastric and duodenal ulcers in rats. Mastic at an oral dose of 500 mg/kg produced a significant reduction in the intensity of gastric mucosal damage induced by pyloric ligation, aspirin, phenylbutazone, reserpine and restraint + cold stress. It produced a significant decrease of free acidity in 6-h pylorus-ligated rats and a marked cytoprotective effect against 50% ethanol in rats which could be reversed by prior treatment with indomethacin. The protective effect was not seen when it was given intraperitoneally in phenylbutazone and restraint + cold stress models. The reduction in the intensity of ulceration in cysteamine-induced duodenal ulcers was not found to be statistically significant in mastic-pretreated rats. The results suggest that mild antisecretory and a localized adaptive cytoprotectant action may be responsible for its anti-ulcer activity. These observations support the results of an earlier study on the clinical effectiveness of mastic in the therapy of duodenal ulcer.